Published in

Springer Nature [academic journals on nature.com], Cellular & Molecular Immunology, 2(21), p. 171-183, 2023

DOI: 10.1038/s41423-023-01104-y

Links

Tools

Export citation

Search in Google Scholar

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”

Journal article published in 2023 by Benjamin L. Sievers ORCID, Mark T. K. Cheng ORCID, Kata Csiba, Bo Meng, Ravindra K. Gupta ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

AbstractAn ancient conflict between hosts and pathogens has driven the innate and adaptive arms of immunity. Knowledge about this interplay can not only help us identify biological mechanisms but also reveal pathogen vulnerabilities that can be leveraged therapeutically. The humoral response to SARS-CoV-2 infection has been the focus of intense research, and the role of the innate immune system has received significantly less attention. Here, we review current knowledge of the innate immune response to SARS-CoV-2 infection and the various means SARS-CoV-2 employs to evade innate defense systems. We also consider the role of innate immunity in SARS-CoV-2 vaccines and in the phenomenon of long COVID.